Originally published In Press as doi:10.1074/jbc.M106918200 on August 20, 2001
J. Biol. Chem., Vol. 276, Issue 44, 40621-40630, November 2, 2001
CBF/NF-Y Functions Both in Nucleosomal Disruption and
Transcription Activation of the Chromatin-assembled Topoisomerase II
Promoter
TRANSCRIPTION ACTIVATION BY CBF/NF-Y IN CHROMATIN IS DEPENDENT
ON THE PROMOTER STRUCTURE*
Françoise
Coustry,
Qianghua
Hu,
Benoit
de Crombrugghe, and
Sankar N.
Maity
From the Department of Molecular Genetics, the University of Texas,
M. D. Anderson Cancer Center, Houston, Texas 77030
Received for publication, July 23, 2001, and in revised form, August 15, 2001
 |
ABSTRACT |
To understand the role of
CCAAT-binding factor (CBF) in transcription in the context of
chromatin-assembled DNA, we used regularly spaced nucleosomal DNA using
topoisomerase II
(topo II
) and
2(1) collagen promoter
templates, which were subsequently reconstituted in an in
vitro transcription reaction. Binding of CBF to the nucleosomal wild-type topo II
promoter containing four CBF-binding sites disrupted the regular nucleosomal structure not only in the promoter region containing the CBF-binding sites but also in the downstream region over the transcription start site. In contrast, no nucleosome disruption was observed in a mutant topo II
promoter containing mutations in all CBF-binding sites. Interestingly, CBF also activated transcription from nucleosomal wild-type topo II
promoter. In this
experiment, a promoter containing one wild-type CBF-binding site was
activated very weakly, whereas the promoter containing mutations in all
sites was not activated by CBF. A truncated CBF that lacked the
glutamine-rich domains did not activate transcription from nucleosomal
wild-type topo II
promoter but disrupted the nucleosomal structure
about as much as did the binding of full-length CBF. Two nucleosomal
mouse
2(1) collagen promoter DNAs, one containing a single and the
other containing four CBF- binding sites, were also reconstituted in an
in vitro transcription reaction. None of the nucleosomal
collagen promoters was activated by CBF. However, both of these
collagen promoters were activated by CBF when the transcription
reaction was performed using naked DNA templates. Binding of CBF to the
nucleosomal collagen promoter containing four binding sites disrupted
the nucleosomal structure, similarly as observed in the topo II
promoter. Altogether this study indicates that CBF-mediated nucleosomal
disruption occurred independently of transcription activation. It also
suggests that specific promoter structure may play a role in the
CBF-mediated transcription activation of nucleosomal topo II
promoter template.
 |
INTRODUCTION |
The chromatin structure plays an important role in the regulation
of transcription in eukaryotic cells. Generally the chromatin produces
a repressive environment for transcription and the repression could
occur at multiple steps of transcription activation (1, 2). Studies
from many laboratories showed that specific DNA-binding proteins that
bind to a particular promoter result in nucleosomal disruption or
remodeling surrounding the promoter region, which then allows
recruitment of coactivators and general transcription machinery to
activate transcription (3-5). Mammalian promoters usually contain
binding sites for various specific DNA-binding proteins. It is now
recognized that the binding of multiple proteins may be required to
disrupt the nucleosomal structure surrounding the promoter in a way
that presets the promoter for subsequent transcription activation
(6-8).
The mammalian CCAAT-binding transcription factor
CBF1/NF-Y is a heterotrimeric
protein consisting of CBF-A, CBF-B, and CBF-C (9, 10). CBF-A and CBF-C
contain histone-fold motifs that are similar to histones H2B and H2A,
respectively (11, 12). CBF contains two glutamine-rich transcription
activation domains, one present in CBF-B and the other in CBF-C (13). A
survey of mammalian promoters showed that about 25% contain
CBF-binding sites (14). The CBF subunits are ubiquitously expressed in
all mammalian tissues.
To understand the in vivo function of CBF, we have recently
inactivated CBF in mouse fibroblast cells by expressing a
dominant-negative CBF-B mutant that inhibits DNA binding of CBF protein
(15). This study showed that the mutant but not the wild-type CBF-B retarded fibroblast cell growth. Analysis of the mRNA profile showed that the inactivation of CBF in fibroblasts decreased the expression of only a small number of cellular genes, many of which are
regulated during cell growth. This study suggested that in cultured
mammalian cells CBF may primarily be involved in transcription of
growth-regulated genes. This is also further supported by the observation that the promoters of various growth-regulated genes such
as thymidine kinase (16), E2F1 (17), topoisomerase II
(topo II
)
(18, 19), cyclin B1 (20), and CDC25C (21) contain multiple CBF-binding
sites. Altogether this analysis implied that the in vivo
transcription activity of only a subset of all promoters containing
CBF-binding sites was affected by the inhibition of CBF binding in fibroblasts.
In this regard it is important to mention that promoters of many
tissue-specific genes that are not expressed in fibroblasts also
contain CBF-binding sites. So it is conceivable that the in
vivo function of CBF is dependent on the state of chromatin structure in the promoter. Indeed recent studies of the chromatin structure of the Xenopus hsp70 promoter showed that the two
CBF-binding sites in this promoter were required to generate a
nuclease-hypersensitive site in chromatin and played an important role
in acetylation-responsive transcription in Xenopus oocyte
nuclei (22). This implied that CBF binding to this promoter altered the
local chromatin architecture in the promoter so that recruitment of
other transcription factors was facilitated. However, it remained to be
determined whether such a function of CBF is specific to the hsp70
promoter or generally applicable to other promoters.
It is possible that transcription of growth-regulated genes whose
promoters contain multiple CBF-binding sites are highly dependent on
CBF. The promoter of the mouse topo II
gene has been
recently isolated (18). The most striking feature of this promoter is
that it contains seven CBF-binding sites within the 210-bp upstream
sequence of this gene and lacks a consensus TATA motif. The topo II
is one of the two isoforms of DNA topoisomerase II enzyme which is a
ubiquitous nuclear enzyme that can alter the topology of DNA and plays
an important role during many cellular processes such as transcription,
replication, recombination, and chromosome segregation. The expression
of topo II
is regulated during cell growth, with an activity that
peaks at G2/M phase of the cell cycle; in contrast
expression of the other isoform, topo II
, is unchanged during the
cell cycle. Thus it is believed that the topo II
isoform plays a
major role during chromosome segregation in mitosis (18).
Here we analyzed the role of CBF in transcription of topo II
promoters using in vitro reconstituted nucleosomal assembled DNA templates. We found that binding of CBF to the wild-type promoter disrupted regular nucleosomal structure not only at the CBF binding regions but also in the downstream promoter region. Interestingly, CBF
also strongly activated transcription of nucleosomal topo II
promoter even after nucleosomes were reconstituted with histone H1,
which strongly repressed transcription. Altogether our results showed
that transcription of nucleosomal topo II
promoter was highly
dependent on CBF-binding sites. Furthermore, we showed that although
CBF activated transcription of collagen promoters in naked DNA
template, it did not activate transcription of nucleosomal collagen
promoter template. This study suggested that a promoter-specific mechanism plays a role in the CBF-dependent transcription
activation of nucleosomal topo II
template.
 |
MATERIALS AND METHODS |
Plasmid Construction--
The reporter plasmids FC1 and FC2
contained the sequence of the mouse
2(I) collagen promoter from pFC1
and pFC2 (23). These promoter sequences were amplified by PCR and
inserted between the KpnI and XhoI sites in the
pGL3-basic vector (Promega). The reporter plasmid PGL3-350 was
constructed by inserting the sequence of the mouse
2(I) collagen
promoter, amplified by PCR from pH 6 (24), between the XhoI
and HindIII sites in the pGL3-basic vector. To construct the
4CCAAT reporter plasmid, the sequence between
170 and +110 of the
mouse topoisomerase II
gene promoter (18) was amplified by PCR and
was cloned between the SacI and XhoI sites in the
pGL3-basic vector. The reporter templates M1-4, W1, and W3, carrying
mutations of the CBF-binding sites in the topo promoter, were obtained
by introducing a point mutation (CCAAT to CCAAA) using PCR, as
indicated in Fig. 1.
Transient Transfection Assays--
Transient transfections were
performed in NIH3T3 cells by using LipofectAMINE reagent (Life
Technologies, Inc.). One day before transfection, NIH3T3 cells were
plated at a density of 2 × 105 cells/well in a 6-well
tissue culture plate in Dulbecco's modified Eagle's medium containing
10% calf serum. The cells, 50-80% confluent, were transfected for
5 h with 1.2 µg of reporter plasmid, 300 ng of internal control
plasmid pSV
gal, and 6 µl of LipofectAMINE reagent (Life
Technologies, Inc.) for each transfection following the procedure
recommended by Life Technologies, Inc. Cells were harvested 48 h
after transfection, and the luciferase activity was assayed as
described (25) using a Monolight 2010 luminometer (PharMingen).
-Galactosidase activity was measured using a Galactolight kit from
Tropix. Each experiment was done in duplicate for two independent experiments.
Generation of Recombinant Proteins--
Full-length and
truncated CBF proteins were expressed in Escherichia coli as
fusion proteins with glutathione S-transferase as described
previously (13, 23).
Nuclear Extracts--
HeLa cells were grown in suspension in
Joklik medium supplemented with 5% calf serum at the density of
0.8 × 106 cells/ml. Nuclear extracts were prepared as
described (26) and then were depleted of CBF as described previously
(23) by mixing with a DNA affinity resin in which the DNA sequence of the mouse
2(I) collagen gene promoter from
105 to
64 was
covalently linked to Sepharose.
Chromatin Assembly--
The S190 extracts were prepared from 0- to 6-h Drosophila embryos (from Canton-S wild-type flies
generously provided by W. Mattox, M. D. Anderson Cancer Center,
Houston, TX) as described by Kadonaga and co-workers (27, 28). These
extracts were supplemented with exogenous core histones prepared from
HeLa cells. HeLa cells were grown for 24 h at 37 °C in medium
containing 8 mM sodium butyrate and then used for the
preparation of chromatin-containing histones according to Wolffe and
Hayes (29). The histones were fractionated following the procedure of
Simon and Felsenfeld (30). In a typical assembly reaction, 30 µl of
S190 extract was incubated with 1.6 µg of purified core histones in
RO buffer (10 mM HEPES, pH 7.5, 10 mM KCl, 0.5 mM EGTA, 10% glycerol, 10 mM
-glycerophosphate, 1 mM dithiothreitol, 0.2 mM phenylmethylsulfonyl fluoride) at room temperature for
30 min. To this sample 10× ATP mix (300 mM creatine
phosphate, 30 mM ATP, 1 µg of creatine phosphokinase, 26 mM MgCl2) was added and incubated for 5 min on
ice. One microgram of plasmid DNA (preincubated or not with CBF for 20 min on ice) was then added, and chromatin assembly was allowed to
proceed for 4.5 h at 27 °C. Purified histones H1, 0.4 or 0.8 µg (kindly provided by S. Majumder, M. D. Anderson, Houston,
TX), were added in some reactions.
In Vitro Transcription--
The topo II
promoter constructs
and the
2(I) collagen promoter constructs, either as naked plasmid
DNA or as chromatin-reconstituted DNA (taken as an aliquot of the
chromatin assembly reaction mixture), were incubated with the
transcription mix (1% polyvinyl alcohol, 1% polyethylene glycol, 1 mM NTPs, 5 mM MgCl2 final
concentration), HeLa nuclear extract, and p120 plasmid DNA (23). The
templates were transcribed for 1 h at 27 °C. Transcription
reactions were stopped with transcription stop buffer (0.4 M NaOAc, pH 5.2, 1% SDS). RNAs were purified by
phenol/chloroform extraction, chloroform extraction, and ethanol
precipitation with glycogen as carrier. RNAs were analyzed by primer
extension as described previously (23).
Micrococcal Nuclease and DNase Digestion--
The chromatin was
digested immediately after chromatin assembly with micrococcal nuclease
(Mnase) for 5, 10, and 20 min or with DNase I for 10 min. The digestion
was stopped by adding stop buffer (TE, EDTA, RNase I) for 15 min at
37 °C. This was followed by proteinase K treatment. The DNA was
purified by phenol/chloroform extraction, chloroform extraction, and
ammonium acetate/ethanol precipitation with glycogen as carrier.
For Mnase ladder, DNA was subjected to electrophoresis on a 1.5%
agarose gel and in some cases transferred to a nylon membrane for
Southern blot analysis. After prehybridization in hybridization buffer
(6.66% SDS, 0.33 M NaPO4, pH 7.2), the
membrane was hybridized with labeled oligonucleotides at 45 °C for
1 h. Washes were carried out in wash buffer (2× SSC (1× SSC is
0.15 M NaCl plus 0.015 M sodium citrate), 0.1%
SDS) briefly at room temperature, 15-min wash in 2× SSC, 0.1% SDS at
45 °C, and 15-min wash in 1× SSC, 0.1% SDS at 45 °C. Sequences
of the various oligonucleotides used are as follows: plasmid-680
(5'-GATAGACGGTTTTTCGCCCTTTGACGTTGG-3'); plasmid-167
(5'-TCTCTATCGATAGGTACCGAGCTC-3'); prom-66
(5'-AAGACGATCTACGATTGGTTACTGCAAACAGAG-3'); prom+37
(5'-CTAGGGAAGCTCTCCTAACCG-3'); prom+109
(5'-AACCAGCGGCTCGAGCTGGGCGACCCGCGA-3'); plasmid+186
(5'-CATTCCGGTACTGTTGGTAAAGCC-3'); plasmid+207
(5'-CTTTATGTTTTTGGCGTCTTCC-3'); plasmid+283
(5'-GTATCTCTTCATAGCCTTATGCAG-3').
Plasmid Footprinting--
DNA, digested with either Mnase or
DNase I, was subjected to linear amplification. The first reaction
mixture was assembled by mixing in a hot-start PCR tube the reaction
buffer with the labeled oligonucleotide and dNTPs. The PCR tube was
heated at 90 °C for 30 s and cooled to room temperature to form
the wax barrier. The second mix containing the DNA, the reaction
buffer, and Vent (exo
) polymerase (New England Biolabs)
was added to the PCR tube. The extension program was run in a PCR
machine (4 min at 95 °C, 8 cycles of 1 min at 94 °C, 3 min of
annealing at 45 °C for primer plasmid +283 and primer plasmid +186,
30 s at 74 °C, and hold at 18 °C). After NaOAc/EtOH
precipitation, the DNA were analyzed on a 6% sequencing gel using a
NaOAc gradient (top buffer, 0.5× TBE; bottom buffer, 1× TBE, 1 M NaOAc).
 |
RESULTS |
The Activity of Topoisomerase II
Promoter Is Highly Dependent on
CBF-binding Sites in Fibroblast Cells--
To analyze the role of
CBF-binding sites in topo II
promoter activity, we inserted the
sequence
251 to +110 of the topo II
gene in a vector 5'
to a luciferase reporter gene. Transfection of this construct into
mouse fibroblast cells showed a high level of promoter activity (data
not shown). Deletion of the promoter sequence from
170 to +110, which
contains four CBF-binding sites, decreased promoter activity only about
20%. However, further deletion significantly reduced promoter
activity. We used the
170 to +110 construct, which is designated here
as 4CCAAT, as a wild-type background to introduce mutations into the
CBF-binding sites. Each of the CBF-binding sites in this construct was
mutated by single nucleotide substitution mutations from CCAAT to CCAAA
or ATTGG to TTTGG (Fig. 1A). A
promoter construct containing mutations in all four CBF-binding sites
(M1-4) showed a 50-fold decrease in promoter activity. The promoter
containing a single CBF-binding site (W1 or W3) retained significant
promoter activity but was 3-4-fold lower than that of the 4CCAAT
construct (Fig. 1B). This result indicated that the activity
of the topo II
promoter is highly dependent on CBF-binding sites
in vivo. In this regard it is important to note that not all
promoters containing a CBF-binding site are dependent to the same
extent on their CBF-binding site. For example, we showed previously
that a mutation in the single CBF-binding site of the mouse
2(1)
collagen promoter resulted in only a 4-fold decrease of promoter
activity (24). To test the possibility that the dependence of promoter
activity on CBF-binding sites may increase with the number of CBF sites
in the promoter, we constructed a promoter that contains four
CBF-binding sites placed before the minimal promoter of the
2(1)
collagen gene, named here as FC1. A mutant promoter, FC2, in which the
four CBF-binding sites of FC1 were mutated by single nucleotide
substitution, was also constructed (Fig. 1A). Previously,
using an in vitro reconstituted transcription system, we
showed that CBF strongly activated the transcription of the FC1 but not
the FC2 promoter (23). In DNA transfection experiments the promoter
activity of FC1 was only 4-fold higher than FC2, similar to the
collagen promoter containing a single CBF-binding site, and the overall
promoter activity of FC1 was about 8-10-fold lower than the 4CCAAT
promoter of topo II
(Fig. 1B). This result suggests that
the presence of multiple CBF-binding sites in the promoter does not
always contribute higher dependence of promoter activity to the CBF
sites.

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 1.
Effect of mutation in CCAAT motif on promoter
activity in mouse fibroblast cells. A, schematic
diagram of luciferase reporter constructs of a wild-type and three
mutants of the topo II promoter (4CCAAT, W1, W3, and
M1-4), and a wild type and mutant of collagen promoter
(FC1 and FC2). The positions of CCAAT boxes in
the topo II promoter with respect to start of transcription at +1
are indicated by the number above each box. Two other start
sites in this promoter, at +55 and 76, are also indicated. Mutant
constructs contain single nucleotide substitutions in each CCAAT motif
changed from either ATTGG to TTTGG or CCAAT to CCAAA, these are
indicated by × within the box. B, promoter
activity of the reporter constructs measured after transient
transfection in mouse fibroblast cells.
|
|
Binding of CBF to Nucleosomal DNA Strongly Disrupts the Regular
Nucleosomal Structure--
Recent studies showed that the two
CBF-binding sites in the Xenopus hsp70 promoter play a role
that presets the chromatin structure, a process that is required for
transcription activation by heat shock (22). This suggests that the
CBF-dependent transcription activation in mammalian cells
may be due, at least in part, to CBF-mediated nucleosome disruption,
which may in turn facilitate recruitment of general transcription
factors to form a preinitiation complex.
To test this possibility, we studied the interaction of recombinant CBF
with nucleosomal promoter DNA reconstituted in vitro. The
DNA templates containing wild-type and mutant topo II
promoters were
incubated with Drosophila embryo extracts and purified human core histones and an ATP-regenerating system as described by Kamakaka et al. (28). Formation of nucleosomes in the DNA template
was verified by Mnase digestion analysis. This showed formation of DNA
ladders of 146 bp and multiples of 146 bp, thus indicating that
regularly spaced nucleosomal arrays had formed on the DNA template
similar to that found in vivo in mammalian or other
eukaryotic cells (Fig. 2B, upper
panel, lanes 1-3 and 10-12). Addition of CBF to the
incubation mixture before (lanes 7-9 and 16-18)
or after formation of nucleosomes (lanes 4-6 and
13-15) did not change the overall nucleosome pattern of the
DNA template. To monitor specifically the nucleosome structure over the
promoter sequence, we performed a Southern blot analysis, hybridizing
the Mnase-digested DNA with a labeled oligonucleotide probe
corresponding to the +37-bp region in the topo II
promoter (see Fig.
2A). This showed that all DNA fragments generated with
wild-type nucleosomal DNA, formed without CBF, hybridized strongly with
the oligonucleotide probe (Fig. 2B, lower panel, lanes
1-3). This indicated that the regular nucleosomal structure was
present over the promoter region probed with the oligonucleotide. In
contrast, incubation of CBF with the nucleosomal wild-type DNA
significantly reduced hybridization (lanes 4-6), and more
strikingly, preincubation of CBF before formation of the nucleosomes
resulted in an almost complete loss of hybridization (lanes
7-9) of the oligonucleotide with the DNA ladders. Incubation of
CBF with nucleosomal mutant DNA, however, did not cause any change in
hybridization efficiency of the oligonucleotides with the DNA ladders
(lanes 10-18). Recently it was reported (31) that
CBF-A/CBF-C interacts with the histone H3-H4 complex in
vitro. However, incubation of CBF-A/CBF-C or CBF-B alone with the
wild-type DNA before or after nucleosome formation did not result in
any alteration in hybridization efficiency of the oligonucleotides with
the DNA ladders (data not shown). This result indicated that specific
binding of CBF to the CCAAT motifs in the topo II
promoter strongly
disrupted the regular nucleosomal structure over the nucleosomal
promoter region.

View larger version (60K):
[in this window]
[in a new window]
|
Fig. 2.
Analysis of nucleosome assembly on topo
II promoter in the presence or absence of
CBF. A, location in the topo II promoter construct
of the different oligonucleotide probes used in Southern blot
hybridization and primer extension analysis. B, analysis of
nucleosomes by Mnase digestion. The wild-type (4CCAAT) and mutant
(M1-4) topo II promoters were first reconstituted with nucleosome
and then digested partially with Mnase for various times (5, 10, and 20 min) as indicated above each lane. CBF was added either
before (+CBFp) or after (+CBF) nucleosome
assembly and allowed to bind for 30 min at 27 °C. After Mnase
digestion the DNA fragments were isolated and then separated on a 1.5%
agarose gel and visualized by ethidium bromide staining (top
panel). A 123-bp ladder was used as a molecular weight marker
(M). The lower panel shows Southern blot analysis
of the separated DNA after transfer to a nylon membrane and
hybridization with the oligonucleotide probe prom+37. C,
Southern blot analysis of the Mnase-digested wild-type topo II
promoter DNA. The hybridization of the blotted membrane was performed
with various oligonucleotide probes as indicated in the figure.
|
|
To monitor the extent of disruption, we performed a Southern blot
analysis of Mnase-digested nucleosomal wild-type and mutant DNA, which
was formed after preincubation with CBF, with a series of
oligonucleotides corresponding to different regions of the promoter and
vector DNA (see Fig. 2A). Hybridization of each
oligonucleotide with Mnase-digested wild-type or mutant nucleosomal DNA
generated without CBF showed patterns of hybridization to DNA ladders
that were identical to those observed in Fig. 2B, lower panel,
lanes 1-3 and 10-12 (data not shown). All
oligonucleotides also hybridized almost equally with the DNA ladders of
mutant nucleosomal DNA preincubated with CBF (Fig. 2C, lower
panel, lanes 1-18). In contrast, hybridization of the +109 and
+207 oligonucleotides to the DNA ladder of wild-type nucleosomal DNA
preincubated with CBF was very significantly reduced, whereas
hybridization of
66 and +283 oligonucleotides was reduced modestly.
The same DNA ladders, however, hybridized very efficiently with the
680 and
167 oligonucleotides. This indicated that binding of CBF to
the nucleosomal topo II
promoter disrupted the regular nucleosomal
structure over the promoter region from
66 to +207.
To monitor more precisely the extent of CBF-mediated nucleosomal
disruption, we analyzed the Mnase-digested nucleosomal DNA with the
primer extension method using a radiolabeled primer that hybridized at
a downstream promoter region (Fig.
3A). Since Mnase cleaves DNA
outside of and not within the nucleosome, the primer extension bands
should correspond to various nucleosomal positions over the promoter
DNA. Our comparison of primer extension bands of wild-type nucleosomal
DNA generated with or without CBF showed that binding of CBF protected
promoter DNA and augmented Mnase cleavage (lanes 1 and
2). The protected Mnase cleavage regions were located over
the CBF-binding sites from positions
66 to
117, whereas regions of
augmented cleavage are located both upstream and downstream of
CBF-binding sites. Most notably, binding of CBF strongly increased
Mnase cleavage at the region containing the start of transcription at
+1, consistent with the observation in Fig. 2C. In contrast,
incubation of CBF with nucleosomal promoter DNA containing mutations in
all four CBF sites (M1-4) did not result in either protection or
augmentation of Mnase cleavage in the promoter region (lanes
5 and 6). However, incubation of CBF with nucleosomal
promoter DNA containing a single wild-type CBF site (W1) located at
position
26 resulted in only a small increase of Mnase cleavage over
the promoter region at the start of transcription (lanes 3 and 4), indicating that the multiple CBF-binding sites are
required for strong disruption of nucleosomal structure over the start
of the transcription region. Overall, the results of Fig. 3A
indicate that CBF specifically disrupted the nucleosomal structure over
the topo II
promoter region from approximately
200 to + 46 bp.
However, it was not clear from this experiment whether this nucleosomal
disruption was due to direct interactions of CBF with the four CBF
sites in topo II
promoter within the nucleosome.

View larger version (77K):
[in this window]
[in a new window]
|
Fig. 3.
Footprinting analysis of interactions between
CBF and nucleosomal topo II promoter
templates. A, nucleosomal promoter templates were first
digested with Mnase for 20 min and then analyzed by primer extension
using a linear amplification method with labeled oligonucleotide
plasmid +186. CBF was incubated with DNA before nucleosomal assembly
(+). The location of CBF-binding sites is indicated at the left
side of the footprint. At the right side, the
open circles indicate protected bands, and the closed
circles represent hypersensitive bands generated by interaction
with CBF. B, nucleosomal templates were first digested with
DNase I and then subjected to primer extension analysis as in
A. CBF was either included before assembly (+p)
or added after assembly (+) and allowed to bind for 30 min at 27 °C.
The location of CBF-binding sites is indicated alongside the footprint.
Open circles indicate protected bands, and closed
circles represent hypersensitive bands generated by interaction
with CBF.
|
|
To determine the sites of interaction of CBF in nucleosomal DNA, we
used DNase I cleavage followed by primer extension analysis. Since
DNase I cleaves DNA within the nucleosome, this method allows one to
envision the interaction of CBF with DNA within the nucleosome. Nucleosomes were formed with the wild-type topo II
promoter 4CCAAT construct in the presence or absence of CBF, as in Fig. 3A.
Nucleosomal DNA was first cleaved by DNase I and then the digested DNA
was visualized by primer extension analysis using the labeled primer as
in the earlier experiment (Fig. 3B, lanes 1-3). In
lane 2 CBF was preincubated with DNA before formation of
nucleosomes, and in lane 3 CBF was incubated after formation
of nucleosomes. The primer extension analysis shows that the
preincubation of CBF with nucleosomal DNA resulted in both protection
and formation of characteristic hypersensitivity sites of DNase I
cleavage in all four CBF-binding regions. Similar hypersensitive and
protected sites were also observed when CBF was incubated after
formation of nucleosomes. This indicates that all four CBF-binding
sites of the topo II
promoter interacted with CBF in nucleosomal
templates and that CBF also bound to the CBF-binding sites in the
promoter even after formation of nucleosomes.
CBF Activates Transcription of Topoisomerase II
Promoter within
the Nucleosome--
To determine whether CBF activates
transcription of the topo II
promoter in chromatin, we reconstituted
nucleosomal DNA with recombinant CBF in an in vitro
transcription reaction using HeLa cell nuclear extracts. Transcription
of wild-type topo II
promoter in a naked DNA template showed that
this promoter contained three major transcription start sites,
designated I-III (Fig. 4A, lane 1). Addition of
-amanitin inhibited transcription from all
three start sites, indicating that the three start sites in the
promoter were transcribed by RNA polymerase II (data not shown). When
endogenous CBF was partially depleted from nuclear extracts by
incubating with a DNA affinity resin containing a CBF-binding site,
transcription of topo II
promoter from start site II was
specifically decreased (lane 2). Interestingly, addition of
CBF to the depleted extract activated transcription of topo II
promoter from start site II very strongly and modestly from start site
III; in contrast, transcription from this start site I was decreased
upon addition of CBF. In the reaction mixture containing mutant topo
II
promoter (M1-4) with mutations in all the four CBF sites, there
was essentially no activation of transcription when CBF was added
(lanes 8-10). It is important to note that in the mutant
promoter there was much less transcription from start site II than from
start site I (lane 8), consistent with the finding that
transcription from start site II was dependent on CBF-binding sites.
Altogether, these results indicate that CBF specifically activated
transcription of the topo II
promoter.

View larger version (46K):
[in this window]
[in a new window]
|
Fig. 4.
Activity of nucleosomal topo
II promoter templates in an in
vitro transcription reaction. A, the
wild-type (4CCAAT) and mutant (M1-4) topo II
promoter as a nucleosomal (chrom) or as a naked
(n) DNA template were transcribed in complete (c)
or partially CBF-depleted (d) HeLa cell nuclear extracts.
CBF was incubated with DNA either before (+CBFp) or after
(+CBF) nucleosome assembly and allowed to bind for 30 min at
27 °C. The transcribed RNA was analyzed by primer extension method.
The 1(III) collagen promoter was transcribed as naked DNA template
and was used as an internal control. The three transcription start
sites I-III of topo II are indicated. B, transcription
of W1 mutant of topo II promoter. This promoter was transcribed
in vitro both as nucleosomal (chrom) and naked
(n) DNA template as described in A. C,
transcription of nucleosomal wild-type topo II promoter in the
presence of histone H1. The reconstitution of nucleosomal assembly on
topo II promoter was performed in the presence of histone H1 at a
molar ratio of 1:1 and 1:2 with respect to amount of histone octamer
versus histone H1. The nucleosomal template
(chrom) was then transcribed in vitro as
described in A. D, transcription of wild-type topo II
promoter in the presence of a truncated CBF protein (CBFmut)
lacking the glutamine-rich domains of CBF-B and CBF-C. The CBFmut
protein was incubated with nucleosomal (chrom) or naked
(n) DNA template either before (+p) or after (+)
nucleosome assembly and allowed to bind for 30 min at 27 °C.
|
|
When transcription was performed using a wild-type nucleosomal topo
II
promoter template, transcription from all three start sites was
observed (lane 4). Although the presence of nucleosomes in
the promoter usually strongly represses transcription, surprisingly the
topo II
promoter within chromatin was transcribed efficiently and
was only modestly repressed when compared with transcription of naked
DNA. With partially CBF-depleted nuclear extract, transcription from
start site II was decreased (lane 5). When CBF was incubated with the promoter DNA either before or after formation of nucleosomes and then reconstituted in the transcription reaction, strong activation of transcription was seen from start site II and modest activation from
start site III (lanes 6 and 7), similar to what
was observed in the naked DNA template. In contrast, when transcription
was performed using mutant nucleosomal promoter DNA (M1-4), almost no
transcription from any start site of the promoter was observed (lanes 11 and 12). Addition of CBF resulted in
very low level activation from start site II (lanes 13 and
14).
A mutant promoter construct containing a single wild-type CBF site (W1)
was also transcribed in vitro both as a naked DNA template
and nucleosomal template. As shown in Fig. 3A, binding of
CBF to W1 did not cause much nucleosomal disruption over the start of
transcription region. In a naked DNA template CBF activated transcription of W1 promoter (Fig. 4B, lanes 1 and
2); however, the level of activation was five times lower
than that of the wild-type template containing four CBF sites.
Transcription of the W1 nucleosomal template resulted in almost no
transcription from any of the three start sites of the promoter, but
addition of CBF resulted in a significant transcription activation,
specifically from start sites II and III (lanes 3 and
4). This indicates that CBF activated transcription of the
nucleosomal topo II
promoter containing a single CBF-binding site,
even though binding of CBF to this promoter resulted in only a modest
nucleosomal disruption. Altogether this result indicated that CBF
specifically activates transcription of nucleosomal topo II
promoter. The strong transcriptional repression from all three start
sites of the mutant nucleosomal promoters suggests that the multiple
CBF-binding sites in the topo II
promoter play an important role to
support basal transcription from all three start sites in chromatin.
Since the activity of the nucleosomal topo II
promoter was not
completely repressed without the addition of recombinant CBF, it was
not clear whether CBF-dependent activation of the
nucleosomal promoter required a partially derepressed state of
nucleosomes. Thus to test whether CBF could activate transcription when
the promoter is in a completely repressed state, we performed the nucleosome reconstitution in the presence of histone H1, which is known
to repress transcription (32). Mnase digestion of nucleosomal DNA
generated with histone H1 produced the characteristic DNA ladder (data
not shown) like that in Fig. 2B; however, the length of
micrococcal digested DNAs was 180 bp and multiples of 180 bp instead of
146 bp and multiples thereof as shown in Fig. 2B. This indicated that the nucleosomes were associated with histone H1. As
expected, the presence of histone H1 strongly increased the repression
of topo II
promoter activity, and addition of a 2-fold molar ratio
of H1 with respect to core histones resulted in an almost complete
repression of transcription of the topo II
promoter (Fig. 4C,
lanes 1, 2, 5, and 6). Interestingly, addition of CBF to the highly repressed nucleosome caused a strong activation of
transcription of the promoter (lanes 3, 4, 7, and
8). This result indicated that CBF activated transcription
of the topo II
promoter within a highly repressed chromatin state
and that this activation was probably due to a function of CBF that
counteracted H1-mediated transcriptional repression.
Since our results showed that binding of CBF to the topo II
promoter
disrupted nucleosomal structure, it is possible that CBF-dependent transcription activation in chromatin was due
to nucleosomal disruption over the region of the start of
transcription. We showed previously that CBF contains two
glutamine-rich transcription activation domains, one present in CBF-B
and the other in CBF-C. When both activation domains of CBF subunits
were deleted, the truncated CBF still binds to DNA as well as the
full-length CBF bound. As expected, the truncated CBF (CBF-mut) did not
activate transcription of the topo II
promoter either with a naked
DNA template or with a nucleosomal template (Fig. 4D, lanes
1-5). DNase I cleavage analysis showed that CBFmut
bound to the nucleosomal promoter as well as full-length CBF (Fig.
5, lanes 4-6). Interestingly, Mnase cleavage analysis showed that binding of CBFmut resulted in a
strong nucleosomal disruption, much like the nucleosomal disruption
produced by full-length CBF (lanes 1-3). This result indicates that the activation domains of CBF did not play a role in the
CBF-mediated nucleosomal disruption, although these domains mediated
transcriptional activation of the nucleosomal topo II
promoter.

View larger version (60K):
[in this window]
[in a new window]
|
Fig. 5.
Interaction of CBFmut protein with the
nucleosomal topo II promoter. The
analysis of CBFmut interaction with the nucleosomal promoter was done
by both Mnase digestion (left) and DNase I digestion
(right) followed by primer extension analysis, as was the
case in Fig. 3, except a labeled oligonucleotide plasmid +283 was used
instead of plasmid +186 for primer extension.
|
|
CBF Disrupts Nucleosomal Structure but Does Not Activate
Transcription of a Nucleosomal Collagen Promoter--
CBF-binding
sites are present in promoters of many mammalian genes, including genes
that are expressed in specific tissues or cell types. The CBF protein
is expressed ubiquitously in all mammalian cell types. However,
transcription of tissue-specific promoters containing CBF-binding sites
is restricted to specific cell types. This suggests that although CBF
activates transcription of the topo II
promoter in chromatin, it may
not activate similarly all mammalian promoters containing CBF-binding
sites. To test this possibility, we reconstituted the in
vitro transcription reaction with the promoter of the mouse
2(1) collagen gene. The collagen promoter contains a single
CBF-binding site located at
80 within the pGL3-350 construct (Fig.
6A). We also constructed a
promoter, FC1, containing four tandem collagen CBF-binding sites upstream of a minimal collagen promoter (
40 to +54). As
expected from our previous studies (13, 23), both promoters were
activated by CBF in the transcription reactions containing naked DNA
(Fig. 6B, lanes 1-3 and 8-10). When the
transcription reaction was performed with nucleosomal promoters, almost
no transcription from either collagen promoter was observed
(lanes 4, 5, 11, and 12), indicating that the
presence of nucleosomes strongly repressed the transcription activity
of these promoters. Surprisingly, addition of CBF to nucleosomal
promoter did not activate the collagen promoters (lanes 6 and 7, and 13 and 14). This result
indicated that CBF is unable to activate transcription of a collagen
promoter even if four CBF-binding sites are introduced in a
configuration similar to the naturally occurring topo II
promoter.

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 6.
Activity of 2(I)
collagen promoter template in the in vitro
transcription assay. A, schematic diagram of
collagen promoter templates. B, the collagen promoter was
transcribed in vitro in HeLa cell nuclear extracts both as
nucleosomal (chrom) and naked (n) DNA templates
and analyzed as described in Fig. 4A. CBF was incubated with
DNA template either before (+p) or after (+) nucleosome
assembly.
|
|
To examine better the CBF-mediated nucleosome disruption of the
collagen promoters, we digested the nucleosomes with Mnase and then
analyzed them by primer extension. Incubation of CBF with the
nucleosomal FC1 collagen promoter containing four CBF-binding sites
resulted in both protection and augmentation of Mnase cleavage (Fig.
7A, lanes 1-3). Although the
alteration of Mnase cleavage was observed mostly within the CBF-binding
site, a strong increase in Mnase cleavage was also observed downstream
of the CBF-binding region, between CBF site I and the TATA box
(lanes 2 and 3). In contrast, incubation of CBF
with the nucleosomal pGL3-350 collagen promoter containing a single
CBF-binding site did not significantly change the Mnase cleavage
pattern (lanes 5 and 6). Thus CBF strongly disrupted nucleosomal structure in the collagen promoter containing four CBF sites but not in the promoter containing a single CBF site.
The interaction of CBF with the nucleosomal collagen promoter was
revealed by Dnase I cleavage followed by primer extension analysis
(Fig. 7B). This showed that incubation of CBF with the FC1
collagen construct before or after formation of nucleosome resulted in
formation of characteristic hypersensitive DNase I cleavage and
protected sites over all four CBF sites (lanes 2 and
3). Similarly incubation of CBF with the pGL3-350 construct also resulted in formation of hypersensitive DNase I cleavage sites
over the single CBF-binding site in the promoter (lanes 5 and 6). This result indicated that CBF interacts with the
nucleosomal collagen promoters much as it does with the nucleosomal
topo II
promoter. Altogether this analysis is consistent with the
earlier observation that binding of multiple CBF molecules to the
collagen promoter is required for CBF-mediated nucleosomal
disruption.

View larger version (94K):
[in this window]
[in a new window]
|
Fig. 7.
Analysis of interaction of CBF with the
nucleosomal 2(I) collagen promoter. The
analysis of interaction between CBF and nucleosomal collagen promoters
was done by both Mnase digestion (A) and DNase I digestion
(B) followed by primer extension analysis, as described in
Fig. 3. CBF was incubated with DNA template either before
(+p) or after (+) nucleosome assembly. The locations of
CBF-binding sites and TATA box are indicated alongside the footprint.
Open circles and closed circles indicate
protected and hypersensitive bands generated by interaction with
CBF.
|
|
Comparison of CBF-mediated nucleosomal disruption in 4CCAAT topo II
and FC1 collagen promoters showed that although the overall nucleosomal
disruption in these two promoters is similar, a difference in
disruption was seen in the region around the start of transcription. In
the topo II
promoter, the start site of transcription activated by
CBF was located within the disrupted nucleosomal region, whereas in the
FC1 collagen promoter almost no nucleosomal disruption was observed
over the area of the start of transcription (Fig. 8). This result may account for the
inability of CBF to activate transcription of the FC1 collagen promoter
in chromatin.

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 8.
Summary of the extent of CBF-mediated
nucleosomal disruption in the different promoter constructs
used.
|
|
 |
DISCUSSION |
We showed that the in vivo transcription activity of
the topo II
promoter was highly dependent on the presence of several CBF-binding sites, since the activity of this promoter was 50 times
higher than the activity of a mutant promoter in which four CBF-binding
sites were mutated. In contrast, the transcription activity of a
collagen promoter with the same number of CBF sites as the topo II
promoter was only four to five times higher than that of a mutant
collagen promoter in which these sites were mutated. Thus this collagen
promoter is much less dependent on CBF-binding sites than the topo
II
promoter. This suggests that the in vivo CBF-mediated
transcription activation is dependent on promoter context. To test
whether the difference in CBF response might be accounted for by the
presence of nucleosomes, we analyzed the role of CBF with in
vitro reconstituted nucleosomal promoter DNAs.
Our results showed that binding of multiple CBF molecules to a promoter
caused extensive nucleosomal disruption, whereas a weak disruption was
observed in the promoter containing a single CBF-binding site. We
hypothesize that in vivo CBF binds to many promoters with
CBF-binding sites, but binding of CBF by itself will disrupt the
regular nucleosomal structure only in promoters that contain multiple
CBF-binding sites. In a promoter with a single site, we speculate that
other transcription factors could be instrumental together with CBF in
causing chromatin disruption.
In our study recombinant CBF specifically activated transcription of
the nucleosomal topo II
promoter. Although the topo II
promoter
contained three major transcription start sites, CBF activated
transcription mainly from one of them, suggesting that another DNA
element might be required for CBF-mediated transcription activation
from this single start site. Interestingly, mutations in all four
CBF-binding sites resulted in no transcription from any of the three
start sites in the nucleosomal mutant template. Similarly, almost no
transcription was seen from the nucleosomal promoter containing a
single CBF-binding site (W1). This indicated that nucleosomes repressed
transcription of the wild-type promoter only modestly but completely
repressed transcription of the mutant promoters. We interpreted this
result as indicating that multiple CBF-binding sites in the wild-type
promoter, in the presence of CBF in nuclear extracts, mediates
nucleosomal disruption and allows transcription from all the start
sites of the wild-type promoter even though transcription from two of
the start sites is not stimulated by CBF. Transcription of the
wild-type promoter was repressed almost completely when nucleosomes
were reconstituted in the presence of histone H1, a situation that has
been observed in other promoters. In this highly repressed condition,
CBF could activate transcription of the wild-type promoter, indicating
that CBF is able to overcome this chromatin-mediated repression.
CBF-mediated transcription activation of the nucleosomal topo II
promoter requires activation domains of CBF. However, truncated CBF
without activation domains binds to the nucleosomal promoter and
disrupts nucleosomal structure similarly to full-length CBF. It is
possible that the histone-fold motifs of CBF-A and CBF-C, which are
required for formation of CBF-DNA complex, may also play a role in
CBF-mediated nucleosomal disruption. Although recent studies of Caretti
et al. (31) showed an interaction between CBF-A/CBF-C and
histones H3/H4 in the absence of CBF-binding sites, we did not observe
any modulation of the nucleosome structure in the wild-type topo II
promoter in the presence of CBF-A/CBF-C only (data not shown). This
indicates that the CBF-A/CBF-C heterodimer by itself does not disrupt
the nucleosomal structure. Thus if the histone fold motifs of the
CBF-A/CBF-C dimer play a role in the nucleosomal disruption, it may
function within the CBF-DNA complex. The activation domains of CBF do
not play any role in CBF-mediated nucleosomal disruption, thus
suggesting that the activation function of CBF is distinct from the
nucleosomal disruption function. In this respect CBF may be similar to
several other transcription factors that activate transcription and
disrupt nucleosomes by separate mechanisms (32-34). Altogether these
results lead us to speculate that in vivo CBF can access the
topo II
promoter within chromatin and interacts with multiple
binding sites in this promoter. Solely through these interactions, CBF disrupts the local nucleosomal structure so as to allow transcription from this promoter to occur. However, in addition to disrupting the
nucleosomal structure, CBF by itself also contributes to activation of
transcription, along with other transcription factors that bind to this promoter.
Although binding of CBF to a nucleosomal collagen promoter disrupted
the nucleosomal structure, transcription activation of the promoter did
not occur. This result was in stark contrast to the
CBF-dependent chromatin disruption of the nucleosomal topo II
promoter that resulted in strong activation of this promoter. It
strongly suggests that CBF-mediated nucleosomal disruption is totally
separated from CBF-mediated transcription activation. Two possible
mechanisms might account for CBF-mediated transcription activation of a
nucleosomal promoter. One of the differences between topo II
and
collagen promoters is the basal promoter sequences. The collagen
promoter contains a consensus TATA motif, and the transcription is
initiated from a single start site. The topo II
promoter does not
contain a TATA motif, and transcription is initiated at multiple start
sites, a process that is probably mediated by various initiator
elements. Thus the mechanism by which the basal preinitiation
transcription complexes are recruited to these two promoters is
different. A first possible mechanism is that CBF might facilitate
recruitment of a basal transcription complex to the nucleosomal
promoter in the context of an initiator element, but not in the context
of a TATA element, and that CBF would favor activation of the topo
II
promoter through an initiator element. A second hypothesis is
based on the extent of CBF-mediated nucleosomal disruption in the
downstream promoter regions of the topo II
and collagen promoters
(Fig. 8). One of the major rate-limiting steps in the transcription
activation process of a nucleosomal promoter is the recruitment of
basal transcription complexes. Since CBF binding to the topo II
promoter containing either four or single wild-type CBF sites resulted
in nucleosomal disruption that extended over the start site of
transcription and activation of transcription from this site, it is
likely that binding of the basal transcription complex to this start
site is highly favored as a result of this nucleosomal disruption. In
contrast the CBF-mediated nucleosomal disruption in the collagen
promoter does not include the TATA element and the transcription start
site, thus suggesting that recruitment of the basal transcription
complex might be inhibited due to the absence of nucleosomal disruption
over the TATA motif. Altogether this analysis suggests that the
structure of a promoter may determine whether CBF will function as a
transcription activator in chromatin.
In this regard one of the well studied examples is the role of CBF in
transcription activation of the major histocompatibility complex class
II promoter (35). The activity of this promoter is determined by the
arrangement of the CBF-binding site (Y element) with an X box
element that interacts with RFX proteins. Changing the orientation of
these two elements resulted in an almost complete inactivation of the
promoter. Interestingly, recent studies showed that a specific
arrangement of these two elements is required for the recruitment of a
specific transcription coactivator, CIITA, which in turn leads to
activation of transcription of this promoter (36). Thus it is possible
that other specific elements in the topo II
promoter similarly favor
CBF-dependent transcription activation in chromatin.
 |
ACKNOWLEDGEMENTS |
We are grateful to William Mattox, Elaine
McGuffin, and Brigitte Dauwalder for their help in setting up the
Drosophila mass cultures. We acknowledge Jessica Tyler in
Jim Kadonaga's laboratory for providing the protocol for linear
amplification. We thank Walter J. Pagel for editorial assistance. The
DNA Core Sequencing Facility was the recipient of NCI Grant CA16672
from the National Institutes of Health.
 |
FOOTNOTES |
*
This work was supported by National Institutes of Health
Grant R01 AR46264 (to S. N. M.) and NCI Grant CA49515 (to B. d. C.) from the National Institutes of Health.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Dept. of Molecular
Genetics, Box 11, the University of Texas, M. D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030. Tel.: 713-792-8943; Fax: 713-794-4295; E-mail: smaity@mdanderson.org.
Published, JBC Papers in Press, August 20, 2001, DOI 10.1074/jbc.M106918200
 |
ABBREVIATIONS |
The abbreviations used are:
CBF, CCAAT-binding
factor;
topo, topoisomerase;
bp, base pair;
PCR, polymerase chain
reaction;
Mnase, micrococcal nuclease.
 |
REFERENCES |
| 1.
|
Kornberg, R. D.,
and Lorch, Y.
(1999)
Cell
98,
285-294
|
| 2.
|
Paranjape, S. M.,
Kamakaka, R. T.,
and Kadonaga, J. T.
(1994)
Annu. Rev. Biochem.
63,
265-297
|
| 3.
|
Armstrong, J. A.,
and Emerson, B. M.
(1996)
Mol. Cell. Biol.
16,
5634-5644
|
| 4.
|
Kal, A. J.,
Mahmoudi, T.,
Zak, N. B.,
and Verrijzer, C. P.
(2000)
Genes Dev.
14,
1058-1071
|
| 5.
|
Tsukiyama, T.,
Becker, P. B.,
and Wu, C.
(1994)
Nature
367,
525-532
|
| 6.
|
Pazin, M. J.,
Sheridan, P. L.,
Cannon, K.,
Cao, Z.,
Keck, J. G.,
Kadonaga, J. T.,
and Jones, K. A.
(1996)
Genes Dev
10,
37-49
|
| 7.
|
Sheridan, P. L.,
Sheline, C. T.,
Cannon, K.,
Voz, M. L.,
Pazin, M. J.,
Kadonaga, J. T.,
and Jones, K. A.
(1995)
Genes Dev.
9,
2090-2104
|
| 8.
|
Wall, G.,
Varga-Weisz, P. D.,
Sandaltzopoulos, R.,
and Becker, P. B.
(1995)
EMBO J
14,
1727-1736
|
| 9.
|
Maity, S. N.,
and de Crombrugghe, B.
(1998)
Trends Biochem. Sci.
23,
174-178
|
| 10.
|
Sinha, S.,
Maity, S. N.,
Lu, J.,
and de Crombrugghe, B.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
1624-1628
|
| 11.
|
Arents, G.,
and Moudrianakis, E. N
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
11170-11174
|
| 12.
|
Baxevanis, A. D.,
Arents, G.,
Moudrianakis, E. N.,
and Landsman, D.
(1995)
Nucleic Acids Res.
23,
2685-2691
|
| 13.
|
Coustry, F.,
Maity, S. N.,
Sinha, S.,
and de Crombrugghe, B.
(1996)
J. Biol. Chem.
271,
14485-14491
|
| 14.
|
Mantovani, R.
(1998)
Nucleic Acids Res
26,
1135-1143
|
| 15.
|
Hu, Q.,
and Maity, S. N
(2000)
J. Biol. Chem.
275,
4435-4444
|
| 16.
|
Arcot, S. S.,
Flemington, E. K.,
and Deininger, P. L.
(1989)
J. Biol. Chem.
264,
2343-2349
|
| 17.
|
Hsiao, K.-M.,
McMahon, S. L.,
and Farnham, P. J.
(1994)
Genes Dev.
8,
1526-1537
|
| 18.
|
Adachi, N.,
Kobayashi, M.,
and Koyama, H.
(1997)
Biochem. Biophys. Res. Commun.
230,
105-109
|
| 19.
|
Isaacs, R. J.,
Davies, S. L.,
Sandri, M. I.,
Redwood, C.,
Wells, N. J.,
and Hickson, I. D.
(1998)
Biochim. Biophys. Acta
1400,
121-137
|
| 20.
|
Cogswell, J. P.,
Godlevski, M. M.,
Bonham, M.,
Bisi, J.,
and Babiss, L.
(1995)
Mol. Cell. Biol
15,
2782-2790
|
| 21.
|
Zwicker, J.,
Gross, C.,
Lucibello, F. C.,
Truss, M.,
Ehlert, F.,
Engeland, K.,
and Muller, R.
(1995)
Nucleic Acids Res.
23,
3822-3830
|
| 22.
|
Li, Q.,
Herrler, M.,
Landsberger, N.,
Kaludov, N.,
Ogryzko, V.,
Nakatani, Y.,
and Wolffe, A. P.
(1998)
EMBO J.
17,
6300-6315
|
| 23.
|
Coustry, F.,
Maity, S. N.,
and de Crombrugghe, B.
(1995)
J. Biol. Chem.
270,
468-475
|
| 24.
|
Goldberg, H.,
Helaakoski, T.,
Garrett, L. A.,
Karsenty, G.,
Pellegrino, A.,
Lozano, G.,
Maity, S. N.,
and de Crombrugghe, B.
(1992)
J. Biol. Chem.
267,
19622-19630
|
| 25.
|
Wood, W. M.,
Kao, M. Y.,
Gordon, D. F.,
and Ridway, E. C.
(1989)
J. Biol. Chem.
264,
14841-14847
|
| 26.
|
Dignam, J. D.,
Lebovitz, R. M.,
and Roeder, R. G.
(1983)
Nucleic Acids Res.
11,
1475-1489
|
| 27.
|
Bulger, M.,
and Kadonaga, J.
(1994)
Methods Mol. Genet.
5,
241-262
|
| 28.
|
Kamakaka, R.,
Bulger, M.,
and Kadonaga, J.
(1993)
Genes Dev.
7,
1779-1795
|
| 29.
|
Wolffe, A. P.,
and Hayes, J. J.
(1993)
Methods Mol. Genet.
2,
314-329
|
| 30.
|
Simon, R. H.,
and Felsenfeld, G.
(1979)
Nucleic Acids Res.
6,
689-696
|
| 31.
|
Caretti, G.,
Motta, M. C.,
and Mantovani, R.
(1999)
Mol. Cell. Biol.
19,
8591-8603
|
| 32.
|
Pazin, M. J.,
Rohinton, T.,
Kamakaka, R. T.,
and Kadonaga, J. T.
(1994)
Science
266,
2007-2011
|
| 33.
|
Kadam, S.,
McAlpine, G. S.,
Phelan, M. L.,
Kingston, R. E.,
Jones, K. A.,
and Emerson, B. M.
(2000)
Genes Dev.
14,
2441-2451
|
| 34.
|
Wong, J.,
Shi, Y. B.,
and Wolffe, A. P.
(1997)
EMBO J.
16,
3158-3171
|
| 35.
|
Zhu, X.-S.,
Linhoff, M. W.,
Li, G.,
Chin, K.-C.,
Maity, S. N.,
and Ting, J. P.-Y.
(2000)
Mol. Cell Biol.
20,
6051-6061
|
| 36.
|
Masternak, K.,
Muhlethaler-Mottet, A.,
Villard, J.,
Zufferey, M.,
Steimle, V.,
and Reith, W.
(2000)
Genes Dev.
14,
1156-1166
|
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles: